{"public_id":"co_63f42d83eb8030bb4ca530c259a67b4d","status":"active","merged_into_public_id":null,"resolved_public_id":"co_63f42d83eb8030bb4ca530c259a67b4d","name":"cancer patients","description":"Patients with cancer included in the blood-sample analysis.","aliases":["patients"],"types":["population"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":252009487,"title":"Association of vitamin B12/ferritin deficiency in cancer patients with methylomic changes at promotors of TET methylcytosine dioxygenases.","citation_count":16,"url":"https://sah.borca.ai/papers/252009487"}],"claims":[{"public_id":"cl_6c15402ccb6d44d6e9b30d79c38d3b1a","text":"Low vitamin B12 and ferritin levels are associated with increased expression of DNMT1, DNMT3a, and DNMT3b in cancer patients.","corpus_id":252009487,"url":"https://sah.borca.ai/claims/cl_6c15402ccb6d44d6e9b30d79c38d3b1a"},{"public_id":"cl_7f684f93c906041caeab257ddf360e74","text":"Vitamin B12 and ferritin deficiency contributes to DNA methylation progression in cancer patients.","corpus_id":252009487,"url":"https://sah.borca.ai/claims/cl_7f684f93c906041caeab257ddf360e74"},{"public_id":"cl_9ec0423770b80ec493664da36b964e87","text":"Low vitamin B12 and ferritin levels are associated with decreased expression of MTR, TET1, and TET3 in cancer patients.","corpus_id":252009487,"url":"https://sah.borca.ai/claims/cl_9ec0423770b80ec493664da36b964e87"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_63f42d83eb8030bb4ca530c259a67b4d","url":"https://sah.borca.ai/concepts/co_63f42d83eb8030bb4ca530c259a67b4d"}